Literature DB >> 19625456

AMPK as a mediator of hormonal signalling.

Chung Thong Lim1, Blerina Kola, Márta Korbonits.   

Abstract

AMP-activated protein kinase (AMPK) is a key molecular player in energy homeostasis at both cellular and whole-body levels. AMPK has been shown to mediate the metabolic effects of hormones such as leptin, ghrelin, adiponectin, glucocorticoids and insulin as well as cannabinoids. Generally, activated AMPK stimulates catabolic pathways (glycolysis, fatty acid oxidation and mitochondrial biogenesis) and inhibits anabolic pathways (gluconeogenesis, glycogen, fatty acid and protein synthesis), and has a direct appetite-regulating effect in the hypothalamus. Drugs that activate AMPK, namely metformin and thiazolidinediones, are often used to treat metabolic disorders. Thus, AMPK is now recognised as a potential target for the treatment of obesity and associated co-morbidities.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19625456     DOI: 10.1677/JME-09-0063

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  109 in total

1.  Augmenting energy expenditure by mitochondrial uncoupling: a role of AMP-activated protein kinase.

Authors:  Susanne Klaus; Susanne Keipert; Martin Rossmeisl; Jan Kopecky
Journal:  Genes Nutr       Date:  2011-12-04       Impact factor: 5.523

Review 2.  Energy dysfunction in Huntington's disease: insights from PGC-1α, AMPK, and CKB.

Authors:  Tz-Chuen Ju; Yow-Sien Lin; Yijuang Chern
Journal:  Cell Mol Life Sci       Date:  2012-05-25       Impact factor: 9.261

Review 3.  Bromodomain coactivators in cancer, obesity, type 2 diabetes, and inflammation.

Authors:  Gerald V Denis
Journal:  Discov Med       Date:  2010-12       Impact factor: 2.970

Review 4.  Bioenergy sensing in the brain: the role of AMP-activated protein kinase in neuronal metabolism, development and neurological diseases.

Authors:  Stephen Amato; Heng-Ye Man
Journal:  Cell Cycle       Date:  2011-10-15       Impact factor: 4.534

5.  Glucagon-like peptide 1 (GLP-1) can reverse AMP-activated protein kinase (AMPK) and S6 kinase (P70S6K) activities induced by fluctuations in glucose levels in hypothalamic areas involved in feeding behaviour.

Authors:  Verónica Hurtado-Carneiro; Carmen Sanz; Isabel Roncero; Patricia Vazquez; Enrique Blazquez; Elvira Alvarez
Journal:  Mol Neurobiol       Date:  2012-02-05       Impact factor: 5.590

6.  Globular adiponectin inhibits ethanol-induced reactive oxygen species production through modulation of NADPH oxidase in macrophages: involvement of liver kinase B1/AMP-activated protein kinase pathway.

Authors:  Mi Jin Kim; Laura E Nagy; Pil-Hoon Park
Journal:  Mol Pharmacol       Date:  2014-05-21       Impact factor: 4.436

7.  Role of cannabinoidergic system on food intake in neonatal layer-type chicken.

Authors:  Abbas Alizadeh; Morteza Zendehdel; Vahab Babapour; Saeed Charkhkar; Shahin Hassanpour
Journal:  Vet Res Commun       Date:  2015-04-23       Impact factor: 2.459

8.  ABI1 and PP2CA phosphatases are negative regulators of Snf1-related protein kinase1 signaling in Arabidopsis.

Authors:  Américo Rodrigues; Mattia Adamo; Pierre Crozet; Leonor Margalha; Ana Confraria; Cláudia Martinho; Alexandre Elias; Agnese Rabissi; Victoria Lumbreras; Miguel González-Guzmán; Regina Antoni; Pedro L Rodriguez; Elena Baena-González
Journal:  Plant Cell       Date:  2013-10-31       Impact factor: 11.277

Review 9.  Points of integration between the intracellular energy sensor AMP-activated protein kinase (AMPK) activity and the somatotroph axis function.

Authors:  Giovanni Tulipano; Lara Faggi; Valeria Sibilia; Andrea Giustina
Journal:  Endocrine       Date:  2012-06-27       Impact factor: 3.633

10.  Non-pungent long chain capsaicin-analogs arvanil and olvanil display better anti-invasive activity than capsaicin in human small cell lung cancers.

Authors:  John D Hurley; Austin T Akers; Jamie R Friedman; Nicholas A Nolan; Kathleen C Brown; Piyali Dasgupta
Journal:  Cell Adh Migr       Date:  2016-05-19       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.